PEDIATRICS Vol. 69 No. 5 May 1982, pp. 646-648
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stagno, S.
Right arrow Articles by Dworsky, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stagno, S.
Right arrow Articles by Dworsky, M. E.

Defects of Tooth Structure in Congenital Cytomegalovirus Infection

Sergio Stagno MD1, Robert F. Pass MD1, Joe P. Thomas DDS1, Juan M. Navia PhD1, and Meyer E. Dworsky MD1

1 Departments of Pediatrics and Microbiology School of Medicine, Institute of Dental Research, and School of Dentistry, University of Alabama in Birmingham, Birmingham, Alabama

In most populations congenital cytomegalovirus (CMV) infections occur with a frequency of 0.5% to 2% of live births. In the newborn period this infection is largely clinically inapparent; only 5% to 10% of infected infants manifest illness.1 In this small group of symptomatic babies, both the type and severity of abnormalities have a wide spectrum.2 The most frequent manifestations are microcephaly, hepatosplenomegaly, petechia, jaundice, and growth retardation. Although signs of central nervous system involvement are not usually evident at birth, they become apparent within the first few years of life in nearly 90% of children with symptoms at birth. The most common manifestations are microcephaly (70%), intellectual impairment (60%), neuromuscular disorder (35%), hearing loss (30%), and chorioretinitis or optic atrophy (22%).